Indoor Air Quality Solutions Gain Traction
Reasonable growth factors consist of rising awareness of the impact by poor air quality on health along with stringent regulations and growing pollution. With urbanization and industrialization, both outdoor and indoor pollution are driving the need for IAQ solutions.
Key Growth Drivers and Opportunities
Rising Consumer Awareness: The market for solutions including air purifiers is being driven in significant measure by growing public awareness of the negative impact that poor indoor air quality has on allergies, respiratory health, and general health. Individuals and families are searching ways to improve their indoor environment and prevent the respiratory illness due to indoor air pollution. High awareness of allergens such as dust mites and pet dander can lead to respiratory health concerns such as allergies and asthma. Healthcare professionals are empowering people for taking proactive health measures such as air purifiers to mitigate the potential risks.
Smart Home Automation: As public knowledge of energy efficiency, comfort, and health grows better, the integration of smart home technology with indoor air quality (IAQ) monitoring systems is accelerating. Such advanced gadgets are able to communicate with air purifiers, HVAC systems, and smart thermostats to automatically modify temperature, ventilation, and filtration in line with real-time air quality data. Consumers are growingly prioritizing the well-focused living spaces, this shift towards smart technologies and IAQ is potential in modern homes.
Challenges
Advanced IAQ monitoring and purification technologies, such as cost-effective and Internet of Things-enabled systems, may have high upfront costs. This can be an important barrier, particularly in nations with poor infrastructure where people are extremely sensitive to pricing. Mitigating such challenges will need cost-effective advancements, education for consumers and supportive policy to fuel further market expansion.
Innovation and Expansion
Axis launches its first environmental sensors, indoor air quality sensors to support cost-effective air quality monitoring
In April 2025, Axis Communication AB has announced AXIS D6210 Air Quality Sensor and AXIS D6310 Air Quality Sensor, the company's first environmental sensors. The new sensors seamlessly integrate with existing Axis solutions to monitor multiple indoor air quality parameters, enabling efficient and appropriate response to indoor air quality issues, including vaping and smoking, and the proactive management and optimization of air quality in almost any indoor environment.
Panasonic Introduces OASYS, a New Whole Home Air Quality Management Solution
In January 2025, Panasonic Introduces OASYS, a New Whole Home Air Quality Management Solution to Support Homeowners' Comfort and Peace-of-Mind. OASYS is a holistic home comfort solution created for modern, high-performance homes this new approach to HVAC supports the comfort and wellbeing of families in their home environment with greater energy efficiency and cost saving advantages compared to traditional systems.
Health Prevention, Expanding Markets
The key players operating the indoor air quality market include Honeywell International Inc., 3M, Carrier, Daikin, Johnson Controls., TRANE, Lennox International Inc., LG Electronics, Panasonic Canada Inc, Sharp Corporation, Koninklijke Philips N.V., SAMSUNG, Dyson, Blueair, and IQAIR. Companies in the market for nutraceutical ingredients seek to create extremely efficient, scientifically supported formulations to promote wellness and health prevention.
About Author:
Prophecy is a specialized market research, analytics, marketing and business strategy, and solutions company that offer strategic and tactical support to clients for making well-informed business decisions and to identify and achieve high value opportunities in the target business area. Also, we help our client to address business challenges and provide best possible solutions to overcome them and transform their business.
TIME BUSINESS NEWS
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Wire
14-08-2025
- Business Wire
Philips Announces Plan for More Than USD 150 Million of New Investment in Manufacturing and R&D in the U.S. to Expand Production of AI-powered Health Technology Innovations
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Philips, a global leader in health technology, today announced a plan for new investments of more than USD 150 million in U.S. manufacturing and research and development (R&D). As part of today's announcement, Philips unveiled the expansion of its Reedsville, PA, manufacturing facility, which produces AI-enabled ultrasound systems for hospitals across the U.S. These investments come on top of Philips' annual USD 900 million R&D investment in the U.S. as well as investments in nearly 17,000 colleagues across 40 facilities in the United States. Philips has employees in every U.S. state supporting innovations used by clinicians and patients in 90% of hospitals across the country. The investment announced today by Philips includes the expansion of its Reedsville, PA, site and the recently announced expansion of Philips' Image Guided Therapy facility in Plymouth, MN. It also includes additional manufacturing and R&D projects which will come over the next several years to support the company's growth in the U.S. The Reedsville site, which currently manufactures transducers, will also customize the software and configurations of ultrasound systems for specific clinical procedures in cardiovascular, general and maternal care following the expansion. As an example, Philips' industry-leading CV ultrasound platform delivers advanced tools to help doctors diagnose structural heart and coronary artery disease quickly and confidently [1]. 'The proposed planned expansion of our manufacturing facilities is a demonstration of our deep commitment to the U.S. region,' said Jeff DiLullo, Chief Region Leader, Philips North America. 'Each year, Philips spends $900 million in R&D in the U.S. to drive innovation and deliver cutting-edge technology that empowers healthcare professionals to diagnose, treat and monitor patients more effectively. Increasing our manufacturing and R&D capabilities will create jobs and accelerate our ability to deliver better care for more people with innovative AI-enabled solutions.' The expansion of the Reedsville site is expected to add 24,000 square feet of manufacturing space in addition to 40,000 square feet of warehouse space and is expected to create 120 skilled manufacturing jobs. The recently announced expansion of Philips' image-guided therapy facility in Plymouth, MN, which includes the construction of a new medtech training center, is expected to create over 150 new jobs. [1] Philips ultrasound: The next dimension in echocardiography About Royal Philips Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people's health and well-being through meaningful innovation. Philips' patient- and people-centric innovation leverages advanced technology and deep clinical and consumer insights to deliver personal health solutions for consumers and professional health solutions for healthcare providers and their patients in the hospital and the home. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, ultrasound, image-guided therapy, monitoring and enterprise informatics, as well as in personal health. Philips generated 2024 sales of EUR 18 billion and employs approximately 67,300 employees with sales and services in more than 100 countries. News about Philips can be found at Forward-looking statements and other important information This release contains certain forward-looking statements with respect to the financial condition, results of operations and business of Philips and certain of the plans and objectives of Philips with respect to these items. Examples of forward-looking statements include statements made about the strategy, estimates of sales growth, future EBITA, future developments in Philips' organic business and the completion of acquisitions and divestments. By their nature, these statements involve risk and uncertainty because they relate to future events and circumstances and there are many factors that could cause actual results and developments to differ materially from those expressed or implied by these statements. This press release contains inside information within the meaning of Article 7(1) of the EU Market Abuse Regulation.
Yahoo
14-08-2025
- Yahoo
Healthcare Innovation Summit Africa Returns to Johannesburg
JOHANNESBURG, South Africa, Aug. 14, 2025 (GLOBE NEWSWIRE) -- The Healthcare Innovation Summit Africa (HISA) 2025, Africa's leading platform for exploring the latest trends and technologies shaping the healthcare industry, will return to Johannesburg on 22 – 23 October 2025 for its 10th annual edition. Organised by , the event will gather senior healthcare professionals, government leaders, innovators, and technology providers from across Africa and beyond. Themed 'Connected Care, Smarter Systems: Building a Digitally Resilient African Health Ecosystem,' HISA 2025 will feature a robust agenda that covers critical areas such as artificial intelligence (AI), the Internet of Things (IoT), robotics, telemedicine, big data analytics, and digital transformation strategies for both public and private healthcare sectors. Confirmed keynote and panel speakers include: Dr Richard Friedland, Group CEO, Netcare Dr. Boris Konrad, Neuroscientist, AI and Memory Expert, Radboudumc (Germany) Andrew Raynes, CIO & SIRO, Royal Papworth Hospital (UK) Nhlanhla Xaba, ICT Manager: Governance & Information Management, Mediclinic Rajeev Eashwari, President, South African Health Informatics Association Taryn Lotz, Head of IT, Aspen Pharmacare Craig Killeen, CEO, Medinformer Joost Pielage, CTO, Quro Medical Quantin van Rensburg, CIO, Platinum Health Medical Scheme Ish Hendricks, CEO, Netclinic With Africa's healthcare industry undergoing rapid transformation, HISA 2025 offers a unique opportunity for stakeholders to gain actionable insights and forge meaningful partnerships. Delegates will benefit from: Visionary keynote presentations from local and international thought leaders Expert-led panel discussions tackling pressing healthcare challenges and opportunities Exhibition showcases of innovative solutions, products, and services Networking opportunities with policymakers, industry leaders, and innovators Click here to register now 'HISA 2025 is not just a conference, it is where the future of African healthcare takes shape,' said the event organisers. 'The event provides a powerful platform for collaboration, innovation, and the exchange of ideas that can positively impact healthcare systems across the continent.' Event Details:Date: 22 – 23 October 2025Venue: Gallagher Convention Centre, Johannesburg, South AfricaEvent Website: About HISAThe Healthcare Innovation Summit Africa is an annual gathering of healthcare professionals, innovators, and policymakers dedicated to exploring and implementing technology-driven solutions that improve healthcare delivery across Africa. CONTACT: Media Contact: Nonhlanhla Kunene Media Contact – IT News Africa Email: events@ Tel: +27 (0)12 012 5801Sign in to access your portfolio
Yahoo
13-08-2025
- Yahoo
Smart Medical Devices Market to Grow at 17.1% CAGR Through 2030
'Smart medical devices are reshaping healthcare through real-time monitoring, early diagnosis, and personalized treatment, driven by innovation, rising demand for remote patient care, and the global shift toward value-based healthcare.' Boston, Aug. 13, 2025 (GLOBE NEWSWIRE) -- According to the latest study from BCC Research, 'Smart Medical Devices: Global Markets' is projected to grow from $87.7 billion in 2025 to $193.3 billion by the end of 2030, at a compound annual growth rate (CAGR) of 17.1% from 2025 through 2030. The report provides a detailed analysis of the global smart medical devices market, segmented by product type, application, and end user. It highlights the growing adoption of implantable, wearable, and non-wearable devices across major medical areas such as cardiovascular health, diabetes management, neurology, and sleep disorders. The study also explores regional market dynamics in North America, Europe, Asia-Pacific, South America, and the Middle East and Africa, identifying major trends, challenges, and innovations driving growth. It concludes with insights into leading market players and their product offerings, emphasizing advances in device performance and functionality. This report is particularly relevant today because smart medical devices are transforming healthcare by enabling real-time monitoring, early diagnosis, and personalized treatment. They play a vital role in managing chronic conditions like diabetes, cardiovascular, and respiratory diseases, while also supporting emergency response and telecare. Their integration with digital platforms enhances data sharing and clinical decision-making, promoting preventive care and reducing hospital visits. As healthcare systems worldwide focus on to improving outcomes and lowering costs, the adoption of smart medical devices is becoming increasingly critical. The factors driving the market's growth include: Increasing Prevalence of Chronic Diseases and Aging Population: The global rise in chronic conditions like diabetes and heart disease, along with a growing elderly population, is driving demand for smart medical devices. These devices help monitor health continuously and manage long-term conditions more effectively, reducing hospital visits and improving patient outcomes. Improved Wireless Communication and Digital Health Technologies: Advances in wireless tech (like 5G, Bluetooth, and cloud computing) have enabled real-time data sharing between patients and healthcare providers. This supports remote monitoring, telehealth, and faster decision-making, making healthcare more accessible and more efficient. Development of Internet of Things (IoT) Technologies in Healthcare: IoT technology connects medical devices to networks, allowing them to collect and transmit health data automatically. This enables predictive care, real-time alerts, and better management of patients and hospital resources, enhancing the overall healthcare ecosystem. Request a sample copy of the global market for smart medical devices report. Report Synopsis Report Metric Details Base year considered 2024 Forecast period considered 2025-2030 Base year market size $75.9 billion Market size forecast $193.3 billion Growth rate CAGR of 17.1% from 2025 to 2030 Segments covered By Product Type, Application, End User, and Region Regions covered North America, Europe, the Asia-Pacific region, South America, and the Middle East and Africa (MEA) Countries covered U.S., Canada, Mexico, Japan, China, India, Rest of Asia-Pacific, the U.K., Germany, France, Italy, Spain, Rest of Europe, Brazil, Argentina, Rest of South America, The Middle East, and Africa Market drivers Increasing prevalence of chronic diseases and an aging population. Improved wireless communication and digital health technologies. Development of Internet of Things (IoT) technologies in healthcare. Interesting facts: Wearables and AI: Demand for wearable health monitors is rising. AI boosts diagnostics and treatments, and the Internet of Medical Things (IoMT) enables remote, proactive care. Smart Medications and Home Care: Devices like smart inhalers and pill trackers improve medication compliance; home healthcare use is growing, making care more patient centric. Emerging startups: ComeBack Mobility Senzo, Inc. Parasym Able Human Motion Biomotum The report addresses the following questions: What are the projected size and growth rate of the market? The global market for smart medical devices was valued at $75.9 billion in 2024 and is projected to reach $193.3 billion by the end of 2030. The market is expected to grow at a CAGR of 17.1% during the forecast period. Which factors are driving the growth of the market? The increasing prevalence of chronic diseases and an aging population improved wireless communication and digital health technologies and the development of IoT technologies in healthcare. Which market segments are covered in the report? The market in this report is segmented into product type, application, and end user. Based on type, the report covers implantable smart medical devices, wearable smart medical devices, and non-wearable smart medical devices. The market is segmented by application into cardiovascular, diabetes, neurology, sleep disorders, and others. End users include hospitals and clinics, home healthcare settings, and others. Which application segment will be dominant through the forecast period? Cardiovascular will be the dominant application in the smart medical devices market. Which region has the largest market share? The North America market for smart medical devices was valued at $34.3 billion in 2024 and is projected to reach $85.8 billion in 2030, at a CAGR of 16.9% during the forecast period. Market leaders include: Abbott Biotronik Boston Scientific Corp. Connectedhealth Debiotech SA Dexcom Inc. F. Hoffmann-La Roche Ltd. Health Care Originals Insulet Corp. Koninklijke Philips N.V. Livanova Plc Medtronic Novo Nordisk A/S Omron Corp. Ypsomed Related reports: Needle-Free Devices: Technologies and Global Markets: This report offers a detailed analysis of the global needle-free devices market, examining current market dynamics, technological advances, and product performance. It includes insights into popular products, clinical trials, new product approvals, and emerging technologies. The market is segmented by product type (such as needle-free injectors and transdermal patches), application (vaccines and insulin delivery), and end-users (hospitals and homecare settings). Regional outlooks are provided for North America, Europe, Asia-Pacific, South America, and the Middle East and Africa, along with profiles of leading companies and their strategic initiatives. Global Implantable Remote Patient Monitoring Devices Market: This report provides an in-depth analysis of the implantable remote patient monitoring (IRPM) devices market, covering product types, medical indications, and end-user segments. It highlights key market players, their rankings, and strategic developments, offering insights into competitive dynamics. The market is segmented into device categories such as cardiovascular, brain, gastrointestinal, respiratory, hematological, and musculoskeletal monitoring. It also examines applications across diseases like cardiovascular conditions, brain disorders, and diabetes. Purchase a copy of the report direct from BCC Research. For further information on any of these reports or to make a purchase, contact info@ About BCC Research BCC Research market research reports provide objective, unbiased measurement and assessment of market opportunities. Our experienced industry analysts' goal is to help you make informed business decisions free of noise and hype. For media inquiries, email press@ or visit our media page for access to our market research library. Any data and analysis extracted from this press release must be accompanied by a statement identifying BCC Research LLC as the source and publisher. CONTACT: BCC Research Corporate HQ: 50 Milk St., Ste. 16, Boston, MA 02109, USA Email: info@ Phone: +1 781-489-7301Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
